Tsang-Hsien Alexander Wu

Title: Tsang-Hsien Alexander Wu: Innovator in Cancer Treatment

Introduction

Tsang-Hsien Alexander Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on combining protein vaccines with mesenchymal stem cells to inhibit tumor growth and metastasis in mammals.

Latest Patents

Wu holds a patent for a method that involves administering an effective amount of stem cells containing a transgene encoding at least one oncogenic protein. This method is designed to inhibit the growth and/or metastasis of tumors in mammals. The stem cells used in this method are immortal and do not exhibit signs of neoplastic transformation. Additionally, the method includes administering a vaccine composition that contains at least one immunogenic protein capable of eliciting antibodies specific to the oncogenic protein. This innovative approach aims to provide a therapeutic kit for effectively combating tumor growth in mammals.

Career Highlights

Throughout his career, Wu has worked with notable companies in the biotechnology sector, including Healthbanks Biotech Co., Ltd. and Kooper Biotech Co., Ltd. His experience in these organizations has allowed him to develop and refine his groundbreaking methods for cancer treatment.

Collaborations

Wu has collaborated with esteemed colleagues such as Win-Ping Deng and Hsiu-Kang Chang. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Tsang-Hsien Alexander Wu is a key figure in the field of cancer treatment, with a focus on innovative methods that combine stem cells and vaccines. His contributions are paving the way for new therapeutic approaches in oncology.